C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2002
08/07/2002	EP1228198A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof
08/07/2002	EP1228197A1 Symbiotic bacteria and their uses
08/07/2002	EP1228097A2 Antimicrobial activity of the first cationic cluster of human lactoferrin
08/07/2002	EP1228096A1 Dog and rabbit motilin receptor orthologs
08/07/2002	EP1228092A1 24 human secreted proteins
08/07/2002	EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport
08/07/2002	EP1228088A2 Novel traf family proteins
08/07/2002	EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
08/07/2002	EP1228082A1 29 human secreted proteins
08/07/2002	EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies
08/07/2002	EP1227827A1 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
08/07/2002	EP1011883B1 Simplified method for biologically cleaning areas of soil contaminated with leftover pollutant mineral oil-based materials
08/07/2002	EP0828819B1 Mutants which produce a potentiator of bacillus pesticidal activity
08/07/2002	EP0636183B1 Compositions and methods for protein structural determinations
08/07/2002	EP0536350B1 Identification of a novel human receptor tyrosine kinase gene
08/07/2002	CN1362994A Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant DNA molecules encoding these enzymes
08/07/2002	CN1362993A PYRF gene and the utilization thereof
08/07/2002	CN1362968A Novel peptides
08/07/2002	CN1362524A Method for producing 5' xanthosine phosphate by using bar-shape bacterial mutable strain to ferment
08/07/2002	CN1362518A Hexulose phosphate isomerase and gene coding said isomerase
08/07/2002	CN1362516A Prepn process of phosphatidase prepn
08/07/2002	CN1362513A Artificial cordyceps culturing medium
08/07/2002	CN1362512A Aerobic cultivation method using sintering metal film
08/07/2002	CN1362011A Xinbao mushroom culturing method utilizing corn stalk
08/07/2002	CN1362010A asafetida mushroom culturing process
08/07/2002	CN1088750C Method for brewing health-care beer by secondary fermentation
08/06/2002	US6429360 Plant pest control
08/06/2002	US6429304 Screening for agents that modulate microtubule depolymerization
08/06/2002	US6429010 Treating schizophrenia
08/06/2002	US6429006 Use of recombinant yeasts expressing the lactate dehydrogenase gene so as to shift the glycolytic flux towards the production of lactic acid for greater yields
08/06/2002	US6429004 Transforming or transfecting a cell with a vector containing a polynucleotide which encodes a polypeptide having amidase activity useful for the production of optically active compounds
08/06/2002	US6429003 Genes encoding denitrification enzymes
08/06/2002	US6428993 Phytophthora or pythium; for producing a gel or protein gelation composition; novel amino acid sequence
08/06/2002	US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme
08/06/2002	US6428984 Cell disruption of hepatitis b surface antigen (hbsag)-expressing cells such as methylotrophic yeast cells using a high pressure homogenizer
08/06/2002	US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing
08/06/2002	US6428978 Producing gelatin and genuine telopeptide collagen in yeasts or other cells by coexpression of dna constructs encoding alpha1(i) and alpha2(i) collagen monomers lacking the c and/or n propeptides
08/06/2002	US6428971 Genes and proteins related to this pathway include: teichoic acid polymerase (or tap), and cdp-glycerol:poly(glycerophosphate) glycerophosphotransferase; rodc gene and proteins
08/06/2002	US6428966 Growth differentiation factor, lefty-1
08/06/2002	US6428961 A nucleotide sequence that encodes histidine tags in each of the three possible reading frames, and nucleic acid is less than 500 nucleotides in length.
08/06/2002	US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
08/06/2002	US6428951 Comprising reassembly of separate fragments of monomeric enzyme wherein reassembly of monomeric enzyme fragments is operated by interaction of molecular domains fused to each monomeric enzyme fragment
08/06/2002	US6428949 Human phosphatase inhibitor protein
08/06/2002	US6428829 Streptococcus thermophilus strain, fermentation process using such strain and product obtained
08/06/2002	US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction
08/06/2002	US6428783 Analyzing bacteria from feces cultures; prophylaxis of irritable bowel syndrome, diarrhea, asthma, fatigue and dermatitis
08/06/2002	CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins
08/06/2002	CA2076060C Compounds named the adenophostins, their preparation and their therapeutic use
08/06/2002	CA1341381C Yeast hybrid vectors and their use for the production of polypeptides
08/02/2002	WO2001055207A1 Nucleic acids, proteins, and antibodies
08/02/2002	CA2395738A1 Nucleic acids, proteins, and antibodies
08/01/2002	WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
08/01/2002	WO2002059351A2 Accessing microbial diversity by ecological methods
08/01/2002	WO2002059339A1 Process for producing cytochrome c
08/01/2002	WO2002059327A2 Sulfatases and methods of use thereof
08/01/2002	WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/01/2002	WO2002059323A2 Aminoacyl trna synthetases
08/01/2002	WO2002059318A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof
08/01/2002	WO2002059313A2 G-protein coupled receptors and nucleic acids encoding same
08/01/2002	WO2002059312A2 Cell adhesion proteins
08/01/2002	WO2002059311A2 Colon cancer marker
08/01/2002	WO2002059308A2 Method of diagnosing and treating cartilage disorders
08/01/2002	WO2002059306A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002	WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor
08/01/2002	WO2002059297A2 A library of a collection of cells
08/01/2002	WO2002059296A2 Concatemers of differentially expressed multiple genes
08/01/2002	WO2002059295A1 Novel serine protease mp493
08/01/2002	WO2002059294A1 Methods and means for producing efficient silencing construct using recombinational cloning
08/01/2002	WO2002059290A2 A method for evolving a cell having desired phenotype and envolved cells
08/01/2002	WO2002059286A2 Adenylate cyclases
08/01/2002	WO2002059283A2 Nucleic acid modification enzymes
08/01/2002	WO2002059282A2 Adipocyte complement related protein zacrp13
08/01/2002	WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002	WO2002059266A2 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
08/01/2002	WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/01/2002	WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/01/2002	WO2002059153A2 Anticoagulants and their uses
08/01/2002	WO2002058735A1 Method of preparing biological materials and preparation produced using same
08/01/2002	WO2002058727A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
08/01/2002	WO2002058712A2 Probiotic compounds derived from lactobacillus casei strain ke01
08/01/2002	WO2002036761A9 Compositions and methods for the diagnosis of cancer
08/01/2002	WO2002031157A3 Shrimp alkaline phosphatase
08/01/2002	WO2002020614A3 Endoglin-specific polypeptide, production and use thereof
08/01/2002	WO2002014495A3 Enhanced homologous recombination mediated by lambda recombination proteins
08/01/2002	WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002	WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2001098453A3 Modified construct downstream of the initiation codon for recombinant protein overexpression
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001083527A3 Glucagon antagonists
08/01/2002	WO2001074863A3 Chlamydia antigens and corresponding dna fragments and uses thereof
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001070955A3 Identification of essential genes in prokaryotes
08/01/2002	WO2001032003A9 For higher basidiomycetes mushrooms grown (as biomass) in submerged culture
08/01/2002	WO2001004267A9 One-step allelic exchange in mycobacteria with conditional transducing phage
08/01/2002	WO2001000672A9 Secreted proteins and uses thereof
08/01/2002	WO2000077040A9 Human intracellular signaling molecules
08/01/2002	US20020104119 Transcription regulatory sequences derived from Chlamydomonas reinhardtii
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors

1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 1489